期刊文献+

肿瘤疗效评价研究进展 被引量:34

Research Progress in Response Evaluating Criteria for Tumors
原文传递
导出
摘要 肿瘤疗效评价是决定病人继续治疗和研究项目是否继续进行的依据,近10年来,国内外肿瘤疗效评价标准正逐步由传统的实体瘤疗效评价标准向新的综合肿瘤疗效评价标准转化。文章就传统化疗药物、分子靶向药物、中医药等疗效评价研究进展作一综述。
出处 《中国肿瘤》 CAS 2009年第7期548-553,共6页 China Cancer
  • 相关文献

参考文献29

  • 1陈智伟,廖美琳.RECIST标准在肿瘤治疗疗效评价中的应用[J].中国肿瘤,2004,13(10):616-618. 被引量:176
  • 2WHO.WHO handbook for reporting results of cancer treatment WHO offset publication No.48[M].Geneva (Switzerland):World Health Organization,1979.
  • 3Miller AB,Hoogstraten B,Staquet M,et al.Reporting resuits of cancer treatment[J].Cancer,1981,47(1):207-214.
  • 4James K,Eisenhaner E,Christian M,et al.Measuring response in solid tumors:unidimensional versus bidimensional measurement[J].J Natl Cancer Inst,1999,91 (6):523-528.
  • 5Padhani AR,Ollivier L.The RECIST (response evaluation criteria in solid tumors) criteria:implications for diagnostic radiologists[J].Br J Radiol,2001,74(887):983-986.
  • 6Therasse P,Arbuck SG,Eisenhaner EA,et al.New guidelines to evaluate the response to treatment in solid tumors.European Organization for Research and Treatment of Cancer,National Cancer Institute of the United States,National Cancer Institute of Canada[J].J Natl Cancer Inst,2000,92(3):205-216.
  • 7Cheson BD,Pfistner B,Juweid ME,et al.Revised response criteria for malignant lymphoma[J].J Clin Oncol,2007,25(5):579-586.
  • 8Johnson JR,Williams G,Pazdur R.End points and United States Food and Drug Administration approval of oncology drugs[J].J Clin Oncol,2003,21(7):1404-1411.
  • 9储大同.2003年临床肿瘤学进展回顾与展望[A].张灿珍,陈明清,秦叔逵.中国临床肿瘤学教育专辑[M].昆明:云南科技出版社,2004.9.
  • 10Buyse M,Thirion P,Carlson RW,et al.Relation between tumour response to first-line chemotherapy and survival in advanced eoloreetal cancer:,a meta-analysis.Meta-Analysis Group in Cancer[J].Lancet,2000,356(9227):373-378.

二级参考文献98

共引文献410

同被引文献405

引证文献34

二级引证文献216

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部